Conflict of Interest
Richard J Harvey is a consultant with Medtronic, Stryker, Novartis, Meda, and NeilMed pharmaceuticals. Research grant funding received from Glaxo-Smith-Kline and Stallergenes. He has been on the speakers’ bureau for Glaxo-Smith-Kline, Meda Pharmaceuticals and Seqirus. Janet Rimmer has honoraria with Sanofi Aventis, Novartis, Mundipharma, BioCSL, and Stallergenes. Larry H Kalish is on the speakers’ bureau at Mylan, Sequiris and Care Pharmaceuticals. Raymond Sacks is a consultant for Medtronic and is on the speaker’s bureau for Meda Pharmaceuticals. All other authors have no financial disclosures or conflicts of interest.